ArticleBiomedical optics express2025
Glucose detection using a tilted fiber Bragg grating coated with a GO-PBA composite layer.
Article in Biomedical optics express, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a prevalent chronic disease that requires continuous monitoring of patients' blood glucose levels during therapeutic management. In this study, we propose and experimentally validate a glucose sensor with a low limit of detection (LOD) and a broad measurement range. The sensor consists of a tilted fiber Bragg grating coated with a graphene oxide (GO) layer on the fiber surface, as well as pyrene-1-boric acid immobilized on the GO layer, functioning as bio-recognition elements for specific glucose detection. Experimental results demonstrate that the LOD of the sensor can reach the nanomolar level (10 nM). Moreover, the sensor exhibits a linear response within the range of 10 nM to 10 μM, while maintaining functionality across a broader measurement range of 10 nM to 20 mM. Furthermore, we evaluated the selectivity of the sensor in comparison with fructose and galactose. The results demonstrate that glucose elicits 2-3 times and 3-5 times stronger responses than fructose and galactose, respectively. Finally, we assessed the practical applicability of the sensor by measuring actual serum glucose concentrations at various levels, and the results indicate that it performs comparably to standard glucose solutions. Owing to its compact size, ease of fabrication, and high sensitivity, the proposed sensor holds significant promise for applications in the biomedical and biochemical fields.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.